Vidipha Central Pharmaceutical JSC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vidipha Central Pharmaceutical JSC with three other
companies in this sector in VIETNAM :
Central Pharmaceutical JSC No3
(2020
sales of 397.56 billion Vietnamese Dong [US$17.25 million]
),
Mediplantex National Pharmaceutical JSC
(521.39 billion Vietnamese Dong [US$22.63 million]
), and
Agimexpharm Pharmaceutical JSC
(494.98 billion Vietnamese Dong [US$21.48 million]
).
Sales Analysis.
Vidipha Central Pharmaceutical JSC reported sales of 696.13 billion Vietnamese Dong (US$30.21 million)
for the
year ending
December of 2020.
This
represents
an
increase of 12.4%
versus 2019, when the company's sales were 619.25 billion Vietnamese Dong .
Sales at Vidipha Central Pharmaceutical JSC have increased during each of the previous five years
(and since 2015, sales have increased a total of 80%).